Structure and inhibition of orotidine 5′-monophosphate decarboxylase from Plasmodium falciparum

Biochemistry

Volumn 47, Issue 12, 2008, Pages 3842-3854

  Langley, David B ^a   Shojaei, Maryam ^a,c   Chan, Camilla ^a   Hiu, Chuen Lok ^a   Mackay, Joel P ^a   Traut, Thomas W ^b   Guss, J Mitchell ^a   Christopherson, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIODIVERSITY; CHEMICAL ANALYSIS; CONFORMATIONS;

INHIBITION PATTERNS; MICHAELIS-MENTEN KINETICS; PLASMODIUM FALCIPARUM;

ENZYME INHIBITION;

OROTIDINE 5' PHOSPHATE DECARBOXYLASE;

ARTICLE; CONTROLLED STUDY; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBSTRATE; GENE OVEREXPRESSION; MICHAELIS MENTEN KINETICS; MOLECULAR WEIGHT; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PURIFICATION;

ANIMALS; BINDING SITES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; ESCHERICHIA COLI; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR WEIGHT; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS; RIBONUCLEOTIDES; SPECIES SPECIFICITY; URIDINE MONOPHOSPHATE;

PLASMODIUM FALCIPARUM;

EID: 41149088218     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702390k     Document Type: Article

References (45)

1. Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., Paulsen, I. T., James, K., Eisen, J. A., Rutherford, K., Salzberg, S. L., Craig, A., Kyes, S., Chan, M. S., Nene, V., Shallom, S. J., Suh, B., Peterson, J., Angiuoli, S., Pertea, M., Allen, J., Selengut, J., Haft, D., Mather, M. W., Vaidya, A. B., Martin, D. M., Fairlamb, A. H., Fraunholz, M. J., Roos, D. S., Ralph, S. A., McFadden, G. I., Cummings, L. M., Subramanian, G. M., Mungall, C., Venter, J. C., Carucci, D. J., Hoffman, S. L., Newbold, C, Davis, R. W., Fraser, C. M., and Barrell, B. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511.
2. Nchinda, T. C. (1998) Malaria: a reemerging disease in Africa. Emerging Infect. Dis. 4, 398-403.
3. Van Dyke, K., Tremblay, G. C., Lantz, C. H., and Szustkiewicz, C. (1970) The source of purines and pyrimidines in Plasmodium berghei. Am. J. Trop. Med. Hyg. 19, 202-208.
4. Sherman, I. W. (1979) Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev. 43, 453-495.
5. Scheibel, L. W., and Scherman, I. W. (1988) Malaria: Principles and Practice of Malariology, (Wernsdorfer, W. H., and McGreggor, I., Eds.) pp 234-242, Churchill Livingstone, London.
6. Floyd, E. E., and Jones, M. E. (1985) Isolation and characterization of the orotidine 5′-monophosphate decarboxylase domain of the multifunctional protein uridine 5′-monophosphate synthase. J. Biol. Chem. 260, 9443-9451.
7. Jones, M. E. (1980) Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annu. Rev. Biochem. 49, 253-279.
8. Livingstone, L. R., and Jones, M. E. (1987) The purification and preliminary characterization of UMP synthase from human placenta. J. Biol. Chem. 262, 15726-15733.
9. Yablonski, M. J., Pasek, D. A., Han, B. D., Jones, M. E., and Traut, T. W. (1996) Intrinsic activity and stability of bifunctional human UMP synthase and its two separate catalytic domains, orotate phosphoribosyltransferase and orotidine-5′-phosphate decarboxylase. J. Biol. Chem. 271, 10704-10708.
10. Radzicka, A., and Wolfenden, R. (1995) A proficient enzyme. Science 267, 90-93.
11. Miller, B. G., and Wolfenden, R. (2002) Catalytic proficiency: the unusual case of OMP decarboxylase. Annu. Rev. Biochem. 71, 847-885.
12. Harris, P., Poulsen, J. C., Jensen, K. F., and Larsen, S. (2002) Substrate binding induces domain movements in orotidine 5′-monophosphate decarboxylase. J. Mol. Biol. 318, 1019-1029.
13. Harris, P., Navarro Poulsen, J. C., Jensen, K. F., and Larsen, S. (2000) Structural basis for the catalytic mechanism of a proficient enzyme: orotidine 5′-monophosphate decarboxylase. Biochemistry 39, 4217-4224.
14. Appleby, T. C., Kinsland, C., Begley, T. P., and Ealick, S. E. (2000) The crystal structure and mechanism of orotidine 5′-monophosphate decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 97 2005-2010.
15. Miller, B. G., Snider, M. J., Short, S. A., and Wolfenden, R. (2000) Contribution of enzyme-phosphoribosyl contacts to catalysis by orotidine 5′-phosphate decarboxylase. Biochemistry 39, 8113-8118.
16. Miller, B. G., Hassell, A. M., Wolfenden, R., Milburn, M. V., and Short, S. A. (2000) Anatomy of a proficient enzyme: the structure of orotidine 5′-monophosphate decarboxylase in the presence and absence of a potential transition state analog. Proc. Natl. Acad. Sci. U.S.A. 97, 2011-2016.
17. Wu, N., and Pai, E. F. (2002) Crystal structures of inhibitor complexes reveal an alternate binding mode in orotidine-5′-monophosphate decarboxylase. J. Biol. Chem. 277, 28080-28087.
18. Wu, N., and Pai, E. F. (2004) Crystallographic studies of native and mutant orotidine 5′ phosphate decarboxylases. Top. Curr. Chem. 238, 23-42.
19. Wu, N., Mo, Y., Gao, J., and Pai, E. F. (2000) Electrostatic stress in catalysis: structure and mechanism of the enzyme orotidine monophosphate decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 97, 2017-2022.
20. Wu, N., Gillon, W., and Pai, E. F. (2002) Mapping the active site-ligand interactions of orotidine 5′-monophosphate decarboxylase by crystallography. Biochemistry 41, 4002-4011.
21. Jencks, W. P. (1975) Binding energy, specificity, and enzymic catalysis: the circe effect. Adv. Enzymol. Relat. Areas Mol. Biol. 43, 219-410.
22. Christopherson, R. I., Lyons, S. D., and Wilson, P. K. (2002) Inhibitors of de novo nucleotide biosynthesis as drugs. Acc. Chem. Res. 35, 961-971.
23. Cinquin, O., Christopherson, R. I., and Menz, R. I. (2001) A hybrid plasmid for expression of toxic malarial proteins in Escherichia coli. Mol. Biochem. Parasitol.i 117, 245-247.
24. Menz, R. I., Cinquin, O., and Christopherson, R. I. (2002) The identification, cloning and functional expression of the gene encoding orotidine 5′-monophosphate (OMP) decarboxylase from Plasmodium falciparum. Ann. Trop. Med. Parasitol. 96, 469-476.
25. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
26. Rawls, J. M., Jr. (1978) Enzymatic synthesis of [6-14C]orotidine 5'-monophosphate and its use in the assay of orotate phosphoribosyltransferase and orotidylate decarboxylase. Anal. Biochem. 86, 107-117.
27. Fyfe, J. A., Keller, P. M., Furman, P. A., Miller, R. L., and Elion, G. B. (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxym-ethyl)guanine. J. Biol. Chem. 253, 8721-8727.
28. Brusilow, S. W., and Hauser, E. (1989) Simple method of measurement of orotic acid and orotidine in urine. J. Chromatogr. 493, 388-391.
29. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
30. Vagin, A., and Teplyakov, A. (1997) MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022-1025.
31. Lamzin, V. S., and Wilson, K. S. (1993) Automated refinement of protein models. Acta Crystallogr., Sect. D 49, 129-147.
32. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D 60, 2126-2132.
33. Lee, B., and Richards, F. M. (1971) The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55, 379-400.
34. Lovell, S. C., Davis, I. W., Arendall, W. B., III, de Bakker, P. I., Word, J. M., Prisant, M. G., Richardson, J. S., and Richardson, D. C. (2003) Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50, 437-450.
35. Traut, T. W., and Temple, B. R. (2000) The chemistry of the reaction determines the invariant amino acids during the evolution and divergence of orotidine 5′-monophosphate decarboxylase. J. Biol. Chem. 275, 28675-28681.
36. Krungkrai, S. R., Prapunwattana, P., Horii, T., and Krungkrai, J. (2004) Orotate phosphoribosyltransferase and orotidine 5′-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum. Biochem. Biophys. Res. Commun. 318, 1012-1018.
37. Brown, G. K., and O'Sullivan, W. J. (1977) Inhibition of human erythrocyte orotidylate decarboxylase. Biochem. Pharmacol. 26, 1947-1950.
38. Miller, B. G., Traut, T. W., and Wolfenden, R. (1998) Effects of Substrate binding determinants in the transition state for orotidine 5′-monophosphate decarboxylase. Bioorg. Chem. 26, 283-288.
39. Dix, D. E., Lehman, C. P., Jakubowski, A., Moyer, J. D., and Handschumacher, R. E. (1979) Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells. Cancer Res. 39, 4485-4490.
40. Poduch, E., Wei, L., Pai, E. F., and Kotra, L. P. (2007) Structural diversity and plasticity associated with nucleotides. J. Med. Chem., in press.
41. Levine, H. L., Brody, R. S., and Westheimer, F. H. (1980) Inhibition of orotidine-5′-phosphate decarboxylase by 1-(5′-phospho-beta-d- ribofuranosyl)barbituric acid, 6-azauridine 5′-phosphate, and uridine 5′-phosphate. Biochemistry 19, 4993-4999.
42. Tokuoka, K., Kusakari, Y., Krungkrai, S. R., Matsumura, H., Krungkrai, J., Horii, T., and Inoue, T. (2007) Structural basis for the decarboxylation of orotidine 5′-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase. J. Biochem., 143, 69-78.
43. Lee, M., Chan, C. W., Mitchell Guss, J., Christopherson, R. I., and Maher, M. J. (2005) Dihydroorotase from Escherichia coli: loop movement and cooperativity between subunits. J. Mol. Biol. 348, 523-533.
44. Langley, D. B., Harty, D. W. S., Jacques, N. A., Hunter, N., Guss, J. M., and Collyer, C. A. (2008) Structure of N-acetyl-β-D- glucosaminidase (GcnA) from the endocarditis pathogen Streptococcus gordonii and its complex with the mechanism-based inhibitor NAG-thiazoline. J. Mol. Biol., in press.
45. Saenger, W., Suck, D., Knappenberg, M., and Dirkx, J. (1979) Theoretical drug design: 6-azauridine-5′-phosphate-its X-ray crystal structure, potential energy maps, and mechanism of inhibition of orotidine-5'-phosphate decarboxylase. Biopolymers 18, 2015-2036.